Unravelling the Mystery Between Structure and Sustained Clinical Outcomes

Targeted biologics have revolutionised the treatment and outlook of patients with inflammatory joint diseases. The combination of high-cost long-term therapy straining healthcare systems with impending expiry of key biologics patents has led to heightened interest in the development of biosimilars....

Full description

Bibliographic Details
Main Authors: Edward Keystone, Leigh Revers, Thomas Dörner
Format: Article
Language:English
Published: European Medical Journal 2016-07-01
Series:European Medical Journal Rheumatology
Subjects:
Online Access:http://emjreviews.com/wp-content/uploads/Unravelling-the-Mystery-Between-Structure-and-Sustained-Clinical-Outcomes.pdf